What is DWE?
Headquartered in the Aberdeen Technology Park, D. Wheatley Enterprises operates as a sophisticated plastics engineering and manufacturing entity. Since its inception in 1990, the company has cultivated a reputation for excellence in injection-molded plastic products, serving critical roles in medical device manufacturing and defense systems, particularly within NBC protection and detection fields. Operating out of a 40,000-square-foot facility, DWE integrates engineering, molding, and assembly operations under strict ISO 9001:2008 quality standards. The firm distinguishes itself through a deep understanding of FDA compliance, documentation, and traceability, providing a comprehensive suite of services that includes rapid prototyping, mold design, and electro-mechanical product development. By bridging the gap between complex systems integration and high-volume manufacturing, DWE serves as a vital partner for clients requiring high-reliability components.
How much funding has DWE raised?
DWE has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in DWE
PPP
Public-Private Partnership
What's next for DWE?
With the recent influx of capital, DWE is poised to scale its engineering and manufacturing infrastructure to meet increasing demand from the biotech and defense sectors. The strategic focus will likely center on enhancing its rapid prototyping capabilities and further refining its systems integration processes to maintain its competitive edge in precision manufacturing. As the company continues to leverage its deep expertise in FDA-compliant production, the current funding will facilitate the modernization of its assembly operations, ensuring that DWE remains a preferred resource for clients seeking to optimize existing product lifecycles or innovate new solutions for mission-critical applications.
See full DWE company page
